Alimta

... Scotland on Sunday - Top Stories - Revealed: Scots patients denied cancer drugs Search Dating Scotsman.com websites News Sport Business The Scotsman Scotland on Sunday Edinburgh Evening News Dating Jobs Motors Property Travel Business Finder Member Centre Web Feeds Media Pack Site Help Digital Archive 1817-1950 Photo Gallery Reader Holidays Scotsman Calendar Fantasy Golf Haggis Hunt Edinburgh Festivals Entertainment Heritage & Culture Leisure Weather Webcams Log in Register now - free!

Member Centre Sunday, 13th November 2005 Sections Top Stories Scotland UK International Sport Business Politics Sci-Tech Health Education Entertainment Gaelic Opinion Games Article Index Features Review Spectrum Other Sites News Sport Business Print Editions The Scotsman Evening News Back Issues Services Free News Email Free Web Feeds Distribution Info Syndication Sun 13 Nov 2005 printer friendly email article Revealed: Scots patients denied cancer drugs RICHARD GRAY HEALTH CORRESPONDENT SCOTTISH cancer patients are being denied access to at least seven potentially life-saving new drugs on cost grounds and as a result of health service bureaucracy.

Scotland on Sunday can reveal that, since March, three key cancer-beating drugs have been rejected for use in the NHS because they were not considered "cost-effective".

Over the same period, at least a further four highly effective anti-cancer medicines have been approved at national level but are s...

... North Jersey Media Group providing local news, sports & classifieds for Northern New Jersey!

Local News News Education Health Sports Entertainment/Living Food/Dining Columnists Lottery Obits Opinion Login Search NorthJersey.com (last 2 weeks) Advanced Search NorthJersey.com Site Map Help & FAQs To Advertise Contact - Internet Newspapers Subscriber Services Subscribe To Advertise E-Tearsheets N.I.E.

(education) Contact - Newspapers TV Commercials Readership North Jersey Media Group www.njmg.com Partners GroundZeroSpirit.org Food Drive NEWS HEALTH Drug sales expected to rise 7% Wednesday, October 26, 2005 By NICOLE OSTROWBLOOMBERG NEWS NEW YORK - Global pharmaceutical sales will grow as much as 7 percent next year to $650 billion, a slower pace than this year, as six billion-dollar drugs face generic rivals for the first time, according to IMS Health Inc.

About $23 billion in products may lose patent protection overall next year, said Murray Aitken, an IMS Health senior vice president, in an interview in New York.

Sales of generic drugs may rise to $45 billion in 2005.

"2006 seems like a pretty pivotal year for the industry, the biggest year ever in terms of drugs likely to lose their patents in key markets," said Aitken.

"The issue in 2006 is whether the generic forms of these products will not only take sales from the branded products but from ...

... PharmaLive: IMS Health Forecasts 6 to 7 Percent Growth for Global Pharmaceutical Market in 2006 REGISTERED USERS TODAY ON PHARMALIVE.COM IMS Health Forecasts 6 to 7 Percent Growth for Global Pharmaceutical Market in 2006 U.S.

Forecast to Grow at 8 to 9 Percent Pace, Up from 6 to 7 Percent in 2005; China Market Remains Robust, Growing 17 to 18 PercentFAIRFIELD, Conn.-(BUSINESS WIRE)-Oct 25, 2005 - IMS Health (NYSE: RX), the world's leading provider of information solutions to the pharmaceutical and healthcare industries, today announced that it expects global pharmaceutical market growth to remain flat in 2005 at 7 - 8 percent, and is forecasting 6 - 7 percent growth in 2006, with total market size reaching U.S.

$640 - 650 billion.

"Several key market events are expected to shape the pharmaceutical industry in 2006," said Murray Aitken, senior vice president, Corporate Strategy, IMS Health.

"These include the introduction of the Medicare drug benefit in the U.S., expected patent loss and generic introduction for six blockbuster products, and continued efforts by local governments to reduce drug spending and manage patient access to branded pharmaceuticals.

While some pharmaceutical companies are taking the necessary steps to address these areas, others must start planning now to ensure continued growth and success." Regional Forecasts The U.S.

market, which accounts for 43 percent of pharmaceutical sales worldwide, will continue to fuel growth in 2006.

IMS forecasts ...